Trial intelligence / Profile preview

Escitalopram study of serotonin and decision-making in healthy adults

NL-OMON59968Phase 4Completed

Sponsor
Radboud University
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of escitalopram, sponsored by Radboud University. Primary endpoint: Behavioral performance on the resource investment task. Started Mar 2025; status: completed.

02

Drugs

escitalopram

Beyond the preview

Go deeper on NL-OMON59968.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON59968.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call